JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB17199

Anti-Thrombin antibody [5G9]

4

(2 Reviews)

|

(7 Publications)

Mouse Monoclonal Thrombin antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Native Full Length Protein corresponding to Human F2.

View Alternative Names

Prothrombin, Coagulation factor II, F2

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Thrombin antibody [5G9] (AB17199)
  • IHC-P

AbReview41773****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Thrombin antibody [5G9] (AB17199)

ab17199 staining Thrombin in human liver tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde, permeabilized with 0.2% Triton X-100 in PBS and blocked with 5% milk for 30 minutes at room temperature; antigen retrieval was by heat mediation in Tris pH 9.0. Samples were incubated with primary antibody (1/100 in PBS) for 16 hours at 4°C. An undiluted Biotin-conjugated horse anti-mouse IgG polyclonal was used as the secondary antibody.

This image is courtesy of an Abreview submitted by Steffen Rickelt

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Thrombin antibody [5G9] (AB17199)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Thrombin antibody [5G9] (AB17199)

IHC image of Thrombin staining in human liver formalin fixed paraffin embedded tissue section, performed on a Leica Bond system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab17199, 10μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Western blot - Anti-Thrombin antibody [5G9] (AB17199)
  • WB

Unknown

Western blot - Anti-Thrombin antibody [5G9] (AB17199)

Thrombin contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted.

All lanes:

Western blot - Anti-Thrombin antibody [5G9] (ab17199) at 1 µg/mL

Lane 1:

Human liver tissue lysate - total protein (<a href='/en-us/products/unavailable/human-liver-tissue-lysate-total-protein-ab29889'>ab29889</a>) at 10 µg

Lane 2:

Human Plasma Total Protein Lysate at 10 µg

Lane 3:

Western blot - Hep G2 nuclear extract lysate (<a href='/en-us/products/tissue-lysates/hep-g2-nuclear-extract-lysate-ab14660'>ab14660</a>) at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/5000 dilution

Predicted band size: 70 kDa

Observed band size: 40 kDa,75 kDa

true

Exposure time: 12min

Western blot - Anti-Thrombin antibody [5G9] (AB17199)
  • WB

CiteAb

Western blot - Anti-Thrombin antibody [5G9] (AB17199)

Thrombin western blot using anti-Thrombin antibody [5G9] ab17199. Publication image and figure legend from Tang, X., Zhang, Z., et al., 2020, Cell Res, PubMed 31811276.

ab17199 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab17199 please see the product overview.

Effects of both apo- and holo-transferrin on thrombin, FXIIa and antithrombin. a Potentiating effects of both apo- and holo-transferrin on thrombin. b, c Representative RP-HPLC analysis (b) and quantification (c) of fibrinopeptide A (FbpA) and fibrinopeptide B (FbpB) released from 5 mg of fibrinogen hydrolyzed by 0.1 NIH unit thrombin mixed with 0, 0.2, 1, or 5 μM apo-transferrin, respectively. d Potentiating effects of both apo- and holo-transferrin on FXIIa. e, f Representative western blot (e) and quantification analysis of kallikrein heavy chain (HC ~52 kDa) (f) released from 10 μg of prekallikrein (PK) hydrolyzed by 0.01 NIH unit FXIIa mixed with 0, 0.2, 1, or 5 μM apo-transferrin (lane 2–5), respectively. Blots of PK, FXIIa heavy chain (FXIIa HC), transferrin, and kallikrein light chain (LC ~36 and 33 kDa) are also shown. g–j Apo- and holo-transferrin block antithrombin (AT)'s inactivation effect on thrombin (g, h) and FXa (i, j). TAT : thrombin–AT complex. HSA : human serum albumin. Data represent mean ± SD of five independent experiments, *p < 0.05, **p < 0.01 by one-way ANOVA with Dunnett's post hoc test. N.S. : no significance; Tf : transferrin

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

5G9

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P

applications

Immunogen

Native Full Length Protein corresponding to Human F2.

P00734

Epitope

not mapped

Specificity

Binds to human thrombin and to a complex of human thrombin with the thrombin inhibitor hirudin.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "10 µg/mL", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Storage buffer
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS, 2.9% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Thrombin also known as Factor II or thrombin protein is a 36 kDa serine protease essential for blood coagulation. It is produced in the liver as prothrombin and activated in the coagulation cascade. Its expression occurs extensively in the liver where it plays an important role in converting soluble fibrinogen into insoluble fibrin forming blood clots. Thrombin also activates various other coagulation factors including Factors V VIII and XI amplifying the coagulation response. Biotinylated thrombin variations help in detection and research applications.
Biological function summary

Thrombin modulates several physiological processes beyond clot formation. It serves as a signaling molecule interacting with protease-activated receptors (PARs) to influence cell functions including proliferation migration and apoptosis. Thrombin forms part of the prothrombinase complex comprised of prothrombin activated Factor X (Xa) and Factor V on phospholipid surfaces. This complex is critical for thrombin generation during the clotting cascade. Thrombin's activity extends to involvement in wound healing and inflammation regulation.

Pathways

Thrombin significantly participates in the coagulation and fibrinolytic pathways. It not only converts fibrinogen to fibrin in the coagulation pathway but also activates inhibitors like antithrombin which regulates thrombin and other protease activities. Thrombin's interaction with fibrinolysis where tPA and plasminogen are substrates integrates clot disintegration processes. Thrombin's connectivity with proteins such as Factor VII Protein C and antithrombin outlines its diverse role in maintaining hemostatic balance.

Thrombin associates with conditions such as venous thromboembolism and disseminated intravascular coagulation (DIC). Dysregulation of thrombin leads to excessive clotting contributing to thromboembolic diseases. In DIC uncontrolled thrombin activity results in systemic coagulation consuming clotting factors and increasing bleeding risk. Its function alongside proteins like Factor V Leiden and antithrombin deficiencies aggravate thrombotic conditions. Research into thrombin inhibitors aids in developing therapeutic strategies for these disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing. Activates coagulation factor XI (F11); activation is promoted by the contact with negatively charged surfaces (PubMed : 2019570, PubMed : 21976677). Triggers the production of pro-inflammatory cytokines, such as MCP-1/CCL2 and IL8/CXCL8, in endothelial cells (PubMed : 30568593, PubMed : 9780208).
See full target information F2

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Molecular neurodegeneration 19:67 PubMed39380021

2024

Heparin-enriched plasma proteome is significantly altered in Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Qi Guo,Lingyan Ping,Eric B Dammer,Duc M Duong,Luming Yin,Kaiming Xu,Anantharaman Shantaraman,Edward J Fox,Todd E Golde,Erik C B Johnson,Blaine R Roberts,James J Lah,Allan I Levey,Nicholas T Seyfried

Annals of medicine and surgery (2012) 86:850-855 PubMed38333285

2024

KRAS-mutant colorectal cancer cell lines cause a prothrombotic state through the upregulation of thrombin: experimental study.

Applications

Unspecified application

Species

Unspecified reactive species

Duogang Xu,Changkang Liao,Jing Tan

Nature biotechnology 40:1601-1609 PubMed35668324

2022

Directed evolution and selection of biostable L-DNA aptamers with a mirror-image DNA polymerase.

Applications

Unspecified application

Species

Unspecified reactive species

Ji Chen,Mengyin Chen,Ting F Zhu

Cell chemical biology 28:1728-1739.e5 PubMed34352225

2021

The role of SERPIN citrullination in thrombosis.

Applications

Unspecified application

Species

Unspecified reactive species

Ronak Tilvawala,Venkatesh V Nemmara,Archie C Reyes,Nicoletta Sorvillo,Ari J Salinger,Deya Cherpokova,Saeko Fukui,Sarah Gutch,Denisa Wagner,Paul R Thompson

International journal of oral and maxillofacial surgery 50:163-170 PubMed32536459

2020

Elevated expression of protease-activated receptor 1 via ΔNp63 down-regulation contributes to nodal metastasis in oral squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

T Hattori,S Kawano,S Tanaka,R Matsubara,T Sakamoto,Y Hashiguchi,N Kaneko,Y Mikami,M Morioka,Y Maruse,R Kitamura,E Hamada,M Hiwatashi,K Oobu,T Kiyoshima,S Nakamura

Cell research 30:119-132 PubMed31811276

2019

Transferrin plays a central role in coagulation balance by interacting with clotting factors.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaopeng Tang,Zhiye Zhang,Mingqian Fang,Yajun Han,Gan Wang,Sheng Wang,Min Xue,Yaxiong Li,Li Zhang,Jian Wu,Biqing Yang,James Mwangi,Qiumin Lu,Xiaoping Du,Ren Lai

Cells 8: PubMed31394759

2019

Clinical Protocol to Prevent Thrombogenic Effect of Liver-Derived Mesenchymal Cells for Cell-Based Therapies.

Applications

Unspecified application

Species

Unspecified reactive species

Louise Coppin,Mustapha Najimi,Julie Bodart,Marie-Sophie Rouchon,Patrick van der Smissen,Stéphane Eeckhoudt,Géraldine Dahlqvist,Diego Castanares-Zapatero,Mina Komuta,Sanne L Brouns,Constance C Baaten,Johan W M Heemskerk,Sandrine Horman,Nathalie Belmonte,Etienne Sokal,Xavier Stéphenne
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com